Victoria P Werth Selected Research

Victoria P Werth Research Topics

Disease

43	Dermatomyositis (Dermatopolymyositis) 12/2024 - 09/2002
35	Cutaneous Lupus Erythematosus 12/2024 - 09/2002
22	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2024 - 04/2011
17	Skin Diseases (Skin Disease) 12/2024 - 12/2002
15	Pemphigus (Pemphigus Vulgaris) 03/2024 - 06/2005
9	Inflammation (Inflammations) 03/2024 - 03/2012
8	Autoimmune Diseases (Autoimmune Disease) 03/2024 - 09/2002
7	Infections 01/2023 - 07/2008
6	Bullous Pemphigoid (Pemphigoid) 03/2024 - 09/2002
6	Neoplasms (Cancer) 12/2023 - 02/2003
6	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021 - 12/2007
5	Localized Scleroderma (Morphea) 04/2021 - 12/2009
5	Osteoporosis 04/2021 - 01/2006
5	Myositis (Idiopathic Inflammatory Myopathies) 02/2021 - 01/2006
4	Dermatitis 03/2021 - 09/2002
3	Bites and Stings (Sting) 01/2024 - 01/2021
3	Exanthema (Rash) 01/2023 - 01/2006
3	Rupture 01/2022 - 01/2020
3	Skin Manifestations 03/2021 - 10/2007
3	Arthritis (Polyarthritis) 01/2018 - 07/2010
3	Discoid Lupus Erythematosus 01/2017 - 03/2009
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022 - 01/2022
2	Neutropenia 01/2022 - 03/2009
2	Rheumatoid Arthritis 12/2021 - 04/2017
2	Body Weight (Weight, Body) 09/2021 - 01/2021
2	Human Influenza (Influenza) 03/2021 - 01/2017
2	Hepatitis 03/2021 - 02/2017
2	Lupus Nephritis 10/2018 - 08/2012
2	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2018 - 10/2016
2	Vasculitis (Vasculitides) 01/2018 - 07/2010
2	Carcinoma (Carcinomatosis) 01/2018 - 09/2015
2	Herpes Zoster 01/2017 - 11/2016
2	Sarcoidosis (Schaumann Disease) 12/2015 - 05/2013
2	Bone Resorption 12/2007 - 06/2006
2	Erythema Nodosum 07/2007 - 01/2003
2	Congenital Abnormalities (Deformity) 07/2007 - 01/2003
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 12/2024
1	Breast Neoplasms (Breast Cancer) 12/2024

Drug/Important Bio-Agent (IBA)

17	Antimalarials (Antimalarial Agents)IBA 10/2022 - 07/2005
11	AutoantibodiesIBA 12/2023 - 09/2002
10	CytokinesIBA 03/2024 - 11/2016
9	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2024 - 09/2002
9	InterferonsIBA 02/2024 - 09/2013
9	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2022 - 04/2017
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2017 - 09/2002
8	GlucocorticoidsIBA 01/2021 - 06/2005
7	Monoclonal AntibodiesIBA 05/2023 - 10/2013
7	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2023 - 01/2006
7	Quinacrine (Mepacrine)IBA 04/2021 - 01/2017
7	Rituximab (Mabthera)FDA Link 01/2021 - 04/2011
6	Interferon Type IIBA 02/2024 - 01/2017
6	Proteins (Proteins, Gene)FDA Link 01/2024 - 12/2002
6	Intravenous Immunoglobulins (IVIG)FDA Link 10/2023 - 08/2003
6	Methotrexate (Mexate)FDA LinkGeneric 01/2023 - 01/2006
5	Immunosuppressive Agents (Immunosuppressants)IBA 07/2022 - 06/2005
5	SteroidsIBA 02/2011 - 06/2005
4	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 08/2012
4	AntibodiesIBA 12/2021 - 08/2012
4	Immunoglobulin A (IgA)IBA 12/2021 - 09/2015
4	MucinsIBA 01/2018 - 05/2007
3	Immunoglobulin G (IgG)IBA 02/2024 - 12/2021
3	lenabasum (ajulemic acid)IBA 12/2023 - 01/2022
3	AntigensIBA 05/2023 - 12/2002
3	Dapsone FDA Link 10/2022 - 06/2005
3	Prednisone (Sone)FDA LinkGeneric 07/2022 - 06/2005
3	iberdomideIBA 04/2022 - 01/2022
3	CannabinoidsIBA 03/2022 - 11/2017
3	ChromatinIBA 01/2022 - 09/2002
3	Antinuclear AntibodiesIBA 11/2019 - 08/2012
3	Chondroitin Sulfates (Chondroitin Sulfate)IBA 07/2012 - 03/2011
3	Thalidomide (Thalomid)FDA Link 04/2012 - 01/2003
3	CollagenIBA 02/2011 - 05/2007
3	Diphosphonates (Bisphosphonates)IBA 12/2007 - 01/2006
2	InterleukinsIBA 03/2024 - 10/2018
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2011
2	Lamin Type B (Lamin B)IBA 01/2022 - 01/2020
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2020
2	Environmental Pollutants (Pollutants, Environmental)IBA 03/2021 - 01/2019
2	Interleukin-12 (IL 12)IBA 10/2018 - 01/2003
2	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 09/2015
2	anifrolumabIBA 01/2018 - 01/2017
2	Prostaglandins AIBA 12/2015 - 05/2013
2	Matrix Metalloproteinases (MMPs)IBA 10/2013 - 02/2003
2	Lenalidomide (CC 5013)FDA Link 04/2012 - 03/2009
2	Hyaluronic Acid (Hyaluronan)IBA 08/2011 - 03/2011
2	Carbon MonoxideIBA 10/2010 - 07/2010
1	Antiphospholipid AntibodiesIBA 12/2024
1	Hormones (Hormone)IBA 12/2024
1	Contraceptive Agents (Contraceptives)IBA 12/2024
1	Gonadal Steroid Hormones (Sex Hormones)IBA 12/2024
1	Agammaglobulinaemia Tyrosine KinaseIBA 03/2024
1	Interleukin-13IBA 03/2024
1	dupilumabIBA 03/2024
1	pyromellitic acid dianhydride-2-hydroxyethyl methacrylate adductIBA 02/2024
1	RSLV-132IBA 02/2024

Therapy/Procedure

33	Therapeutics 03/2024 - 07/2005
2	Lasers (Laser) 01/2023 - 01/2021
2	Drug Therapy (Chemotherapy) 01/2018 - 12/2006
2	Chemoprevention 01/2018 - 09/2015
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 12/2024